Immagina Biotechnology Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
11
Immagina Biotechnology General Information
Description
Developer of ribosome profiling and translational research technologies designed to break down walls in complex translational studies. The company's platform for ribosome profiling, tRNA biology, and tRNA sequencing enables biotechnology researchers with the ability to achieve meaningful results in RNA-focused projects.
Contact Information
Website
www.immaginabiotech.comCorporate Office
- Viale dell'Industria 47
- 38057 Pergine Valsugana
- Italy
Corporate Office
- Viale dell'Industria 47
- 38057 Pergine Valsugana
- Italy
Immagina Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | 02-Jun-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 01-Feb-2020 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 28-Nov-2016 | Completed | Startup | |||
| 3. Angel (individual) | 01-Jan-2016 | Completed | Startup | |||
| 2. Grant | 01-Apr-2015 | $64.7K | Completed | Startup | ||
| 1. Accelerator/Incubator | Completed | Startup |
Immagina Biotechnology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Immagina Biotechnology Patents
Immagina Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4506467-A1 | Method and kit for diagnosis, prognosis, therapy monitoring or outcome prediction assessment of a disease | Active | 07-Aug-2023 | ||
| EP-4506467-B1 | Method and kit for diagnosis, prognosis, therapy monitoring or outcome prediction assessment of a disease | Active | 07-Aug-2023 | ||
| US-20250051845-A1 | Method and kit for diagnosis, prognosis, therapy monitoring or outcome prediction assessment of a disease | Pending | 07-Aug-2023 | ||
| JP-2025028816-A | Method and kit for diagnosis, prognosis, therapy monitoring or outcome prediction assessment of disease | Pending | 07-Aug-2023 | ||
| JP-2025028815-A | Method and kit for identifying molecular markers of disease | Pending | 07-Aug-2023 | C12Q1/6886 |
Immagina Biotechnology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Immagina Biotechnology Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EIT Health | Accelerator/Incubator | Minority | ||
| Tyrolean Business Angel | Angel Group | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Hermann Hauser Investment | Venture Capital | Minority |
Immagina Biotechnology FAQs
-
When was Immagina Biotechnology founded?
Immagina Biotechnology was founded in 2014.
-
Where is Immagina Biotechnology headquartered?
Immagina Biotechnology is headquartered in Pergine Valsugana, Italy.
-
What is the size of Immagina Biotechnology?
Immagina Biotechnology has 22 total employees.
-
What industry is Immagina Biotechnology in?
Immagina Biotechnology’s primary industry is Discovery Tools (Healthcare).
-
Is Immagina Biotechnology a private or public company?
Immagina Biotechnology is a Private company.
-
What is Immagina Biotechnology’s current revenue?
The current revenue for Immagina Biotechnology is .
-
How much funding has Immagina Biotechnology raised over time?
Immagina Biotechnology has raised $1.63M.
-
Who are Immagina Biotechnology’s investors?
EIT Health, Tyrolean Business Angel, , , and Hermann Hauser Investment are 5 of 11 investors who have invested in Immagina Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
